Skip to main content
Microbix Biosystems Inc. logo

Microbix Biosystems Inc. — Investor Relations & Filings

Ticker · MBX ISIN · CA59501P1045 TSX Manufacturing
Open in API
Filings indexed 214 across all filing types
Latest filing 2025-12-03 Regulatory Filings
Country CA Canada
Listing TSX MBX

About Microbix Biosystems Inc.

https://microbix.com/

Microbix Biosystems Inc. develops and commercializes proprietary biological and technological solutions for human health, specializing in infectious disease diagnostics. The company is a commercial-scale producer of infectious disease antigens, which are utilized as key ingredients in manufacturing diagnostic tests and for vaccine research and development. Microbix also provides a comprehensive portfolio of external quality control materials (EQC), marketed as Quality Assessment Products (QAPs™). These whole-workflow, multi-analyte controls, available in liquid and swab formulations for IVD and Research Use Only (RUO) applications, support clinical laboratory proficiency testing and assay development across various infectious disease panels, including respiratory, STI, HPV, and gastrointestinal pathogens. The company is ISO 9001 and 13485 accredited, serving the global diagnostics industry.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings Classification · 1% confidence The document is a press release issued by Microbix Biosystems Inc. announcing a business collaboration with Seegene Mexico. It details the nature of the partnership, provides background on both companies, and includes standard forward-looking statements. It does not fit into specific financial reporting categories like 10-K, IR, or ER, nor is it a regulatory filing of a specific type like a dividend notice or director dealing. As it is a general corporate announcement regarding business operations, it falls under the 'Regulatory Filings' (RNS) category as a catch-all for miscellaneous corporate news.
2025-12-03 English
News release - English.pdf
Regulatory Filings Classification · 1% confidence The document is a corporate news release announcing a cybersecurity incident and remediation measures. It is not an annual or quarterly report, earnings release, AGM material, financing update, legal proceeding, or any other specific filing type. It does not provide financial data, voting results, or attach a report. As a standalone press release that does not fit into any specialized category, it defaults to a general regulatory announcement under Regulatory Filings (RNS).
2025-11-05 English
News release - English.pdf
Report Publication Announcement Classification · 1% confidence The document is a press release announcing the schedule for the upcoming Q3 Fiscal 2025 results release and webinar, but does not contain actual financial results. It informs investors of the timing and format for the report publication rather than providing the actual report or earnings figures. This matches the definition of a Report Publication Announcement (RPA).
2025-08-07 English
News release - English.pdf
Regulatory Filings Classification · 1% confidence The document is a corporate press/news release announcing a new product launch (QUANTDx™ reference materials) with forward-looking statements. It does not present financial results (so not ER or IR), is not an investor presentation (IP), not a report publication announcement (RPA), and does not fit any other specific category. As a generic corporate announcement, it falls into the fallback “Regulatory Filings” category (RNS).
2025-07-29 English
News release - English.pdf
Regulatory Filings Classification · 1% confidence The document is a corporate news release announcing the execution of a multi-year supply agreement between Microbix and Bulgaria’s NCIPD. It does not present financial results, AGM materials, regulatory tests, management changes, financing activities, share transactions, or other specific report types defined in the taxonomy. It is a general corporate announcement and thus falls into the fallback category for miscellaneous regulatory filings.
2025-07-08 English
News release - English.pdf
Regulatory Filings Classification · 1% confidence The document is a corporate news release announcing attendance and presentation at a conference (Asia Pacific POC 2025). It does not contain financial results, voting items, management changes, or other specific regulatory filings, nor is it an investor presentation deck or detailed financial report. It is a general announcement about corporate activities and forward‐looking information, which best fits the fallback category “Regulatory Filings (RNS).”
2025-06-17 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.